Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apollomics, Inc. stock logo
APLMW
Apollomics
$0.01
-2.2%
$0.02
$0.00
$0.05
N/AN/A26,037 shs9,010 shs
Alpha Tau Medical Ltd. stock logo
DRTSW
Alpha Tau Medical
$2.00
-15.6%
$1.51
$0.20
$2.99
N/AN/A55,643 shs18,187 shs
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
$0.04
-0.3%
$0.05
$0.03
$0.16
N/AN/A12,420 shs1,100 shs
ZIVO Bioscience, Inc. stock logo
ZIVOW
ZIVO Bioscience
$0.03
$0.00
$1.00
N/AN/A32,142 shsN/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apollomics, Inc. stock logo
APLMW
Apollomics
-9.46%+1.52%-16.25%+3.88%-36.19%
Alpha Tau Medical Ltd. stock logo
DRTSW
Alpha Tau Medical
-6.51%-0.42%+139.39%+142.48%+934.93%
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
+0.26%-1.53%-15.87%-3.25%-35.28%
ZIVO Bioscience, Inc. stock logo
ZIVOW
ZIVO Bioscience
0.00%-97.78%-99.81%-99.64%-99.98%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apollomics, Inc. stock logo
APLMW
Apollomics
$0.01
-2.2%
$0.02
$0.00
$0.05
N/AN/A26,037 shs9,010 shs
Alpha Tau Medical Ltd. stock logo
DRTSW
Alpha Tau Medical
$2.00
-15.6%
$1.51
$0.20
$2.99
N/AN/A55,643 shs18,187 shs
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
$0.04
-0.3%
$0.05
$0.03
$0.16
N/AN/A12,420 shs1,100 shs
ZIVO Bioscience, Inc. stock logo
ZIVOW
ZIVO Bioscience
$0.03
$0.00
$1.00
N/AN/A32,142 shsN/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apollomics, Inc. stock logo
APLMW
Apollomics
-9.46%+1.52%-16.25%+3.88%-36.19%
Alpha Tau Medical Ltd. stock logo
DRTSW
Alpha Tau Medical
-6.51%-0.42%+139.39%+142.48%+934.93%
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
+0.26%-1.53%-15.87%-3.25%-35.28%
ZIVO Bioscience, Inc. stock logo
ZIVOW
ZIVO Bioscience
0.00%-97.78%-99.81%-99.64%-99.98%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apollomics, Inc. stock logo
APLMW
Apollomics
0.00
N/AN/AN/A
Alpha Tau Medical Ltd. stock logo
DRTSW
Alpha Tau Medical
0.00
N/AN/AN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
0.00
N/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVOW
ZIVO Bioscience
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apollomics, Inc. stock logo
APLMW
Apollomics
$8.50MN/AN/AN/AN/AN/A
Alpha Tau Medical Ltd. stock logo
DRTSW
Alpha Tau Medical
N/AN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
$1.00MN/AN/AN/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVOW
ZIVO Bioscience
$15.85KN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apollomics, Inc. stock logo
APLMW
Apollomics
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Alpha Tau Medical Ltd. stock logo
DRTSW
Alpha Tau Medical
N/AN/AN/AN/AN/AN/AN/AN/A8/18/2026 (Estimated)
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVOW
ZIVO Bioscience
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Apollomics, Inc. stock logo
APLMW
Apollomics
N/AN/AN/AN/AN/A
Alpha Tau Medical Ltd. stock logo
DRTSW
Alpha Tau Medical
N/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/AN/AN/AN/AN/A
ZIVO Bioscience, Inc. stock logo
ZIVOW
ZIVO Bioscience
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Apollomics, Inc. stock logo
APLMW
Apollomics
N/A
Alpha Tau Medical Ltd. stock logo
DRTSW
Alpha Tau Medical
N/A
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
N/A
ZIVO Bioscience, Inc. stock logo
ZIVOW
ZIVO Bioscience
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Apollomics, Inc. stock logo
APLMW
Apollomics
59N/AN/ANot Optionable
Alpha Tau Medical Ltd. stock logo
DRTSW
Alpha Tau Medical
80N/AN/ANot Optionable
60 Degrees Pharmaceuticals, Inc. stock logo
SXTPW
60 Degrees Pharmaceuticals
2N/AN/ANot Optionable
ZIVO Bioscience, Inc. stock logo
ZIVOW
ZIVO Bioscience
8N/AN/ANot Optionable

Recent News About These Companies

Maxim Group Sticks to Their Hold Rating for Zivo Bioscience (ZIVO)
Feeding algae to poultry could halt spread of low path AI
ZIVO Bioscience to Present at The Microcap Conference 2025
ERGO Entia Biosciences, Inc.
Directory Details
ZIVO Bioscience Announces Reverse Stock Split

New MarketBeat Followers Over Time

Media Sentiment Over Time

Apollomics stock logo

Apollomics NASDAQ:APLMW

$0.01 0.00 (-2.24%)
As of 11:05 AM Eastern

Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc. was incorporated in 2016 and is based in Foster City, California with additional locations in Hangzhou and Shanghai, China and Southbank, Australia.

Alpha Tau Medical stock logo

Alpha Tau Medical NASDAQ:DRTSW

$2.00 -0.37 (-15.61%)
Closing price 03:54 PM Eastern
Extended Trading
$2.00 0.00 (0.00%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

60 Degrees Pharmaceuticals stock logo

60 Degrees Pharmaceuticals NASDAQ:SXTPW

$0.04 0.00 (-0.26%)
As of 03:46 PM Eastern

60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.

ZIVO Bioscience stock logo

ZIVO Bioscience NASDAQ:ZIVOW

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.